Prostate Perform
Natural health product licensed in Canada
- Licence holder
- New Roots Herbal Inc.
- NPN or DIN-HM
- 80105501
- Status
- Active licence
- Licence date
- 21 October 2020
- Revision date
- 14 January 2025
- Form
- Liquides
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 10 mg | Not calculated |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 500 mg Potency : 5 % Silicic acid | 25 mg | Not calculated |
| Urtica dioica Source : Sommité Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 500 mg Potency : 5 % Silicic acid | 25 mg | Not calculated |
| Mélange de concentré de tocophérol Source : Glycine max - Graine | 38 mg | Not calculated |
| Acide aminoacétique Source : Chlorhydrate de glycine | 50 mg | Not calculated |
| Sélénium Source : Sélénométhionine | 50 microgram | Not calculated |
| Serenoa repens Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 1,600 mg Potency : 95 % Fatty acids | 160 mg | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 37 mg Campesterol | Not specified | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 74 mg beta-Sitosterol | Not specified | Not calculated |
| Solanum lycopersicum Source : Chair (fruit) | 0.6 mg | Not calculated |
Non-medicinal ingredients
Lécithine, Huile de graine de citrouille
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Cuillère à thé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow/ incomplete voiding/frequent daytime/night time urination) associated with mild to moderate benign prostatic hyperplasia (BPH). Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Helps (to) maintain/support immune function. Helps in connective tissue formation. Helps in energy metabolism and tissue formation.Helps in the absorption (and use) of calcium and phosphorus. Helps to form red blood cells. Helps to maintain healthy bones, hair, nail and/or skin. Maintains good health. Source of/An antioxidant for the maintenance of good health. Source of antioxidant(s)/Provides antioxidant(s). Pollen extract nay help relieve the urologic symptoms (e.g. incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80105501
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.